Remgro traded at 21,286.00 this Friday November 13th, decreasing 64.00 or 0.30 percent since the previous trading session. Looking back, over the last four weeks, Remgro lost 3.34 percent. Over the last 12 months, its price rose by 21.21 percent. Looking ahead, we forecast Remgro to be priced at 20,583.56 by the end of this quarter and at 18,612.30 in one year, according to Trading Economics global macro models projections and analysts expectations.
Remgro Limited is an investment holding company. The Company's investment portfolio includes over 30 investee companies. The Company focuses on approximately seven industries, including food, liquor and home care; banking; healthcare; insurance; industrial; infrastructure, and media and sport. Its investments consist of both listed and unlisted companies. The Company manages its investments on a decentralized basis and its involvement is concentrated on the provision of support rather than on being involved in the day-to-day management of business units of investees. Its other investments include associated companies and joint ventures. The Company's subsidiaries include RCL Foods Limited (listed) and Wispeco Holdings Proprietary Limited (Wispeco (unlisted)). The Company invests in Mediclinic International Limited, RMB Holdings Limited, RMI Holdings Limited, Unilever SA and Air Products South Africa Proprietary Limited, among others.